{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:52:07Z","timestamp":1765975927852},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/ico.0b013e31820ca19e","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T09:11:31Z","timestamp":1323162691000},"page":"188-190","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of Bevacizumab Against Interface Neovascularization After Deep Anterior Lamellar Keratoplasty"],"prefix":"10.1097","volume":"31","author":[{"given":"Elena","family":"Jarr\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Ruiz-Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Mendivil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210204","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/ICO.0b013e318180e50f","article-title":"Bevacizumab (Avastin) and argon laser to treat neovascularization in corneal transplant surgery.","volume":"27","author":"Gerten","year":"2008","journal-title":"Cornea"},{"key":"R2-17-20210204","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.ophtha.2007.05.016","article-title":"Bevacizumab for graft rejection.","volume":"114","author":"Harooni","year":"2007","journal-title":"Ophthalmology"},{"key":"R3-17-20210204","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcrs.2007.07.012","article-title":"Subconjunctival bevacizumab for vascularised rejected corneal grafts.","volume":"33","author":"Awadein","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R4-17-20210204","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.ophtha.2009.03.031","article-title":"Herpes simplex virus keratitis: histopathologic inflammation and corneal allograft rejection.","volume":"116","author":"Shtein","year":"2009","journal-title":"Ophthalmology"},{"key":"R5-17-20210204","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.eye.6702079","article-title":"Intralamellar haemorrhage 44 years following lamellar keratoplasty.","volume":"20","author":"Lee","year":"2006","journal-title":"Eye"},{"key":"R6-17-20210204","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ajo.2007.06.001","article-title":"Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.","volume":"144","author":"Miserocchi","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R7-17-20210204","first-page":"1201","article-title":"Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis.","volume":"92","author":"Godblum","year":"2008","journal-title":"Ophthalmology"},{"key":"R8-17-20210204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00003226-199905000-00001","article-title":"Central lamellar keratoplasty for optical indications.","volume":"18","author":"Soong","year":"1999","journal-title":"Cornea"},{"key":"R9-17-20210204","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/09273940902802683","article-title":"Feasibility study of lamellar keratoplasty in a murine model.","volume":"17","author":"Huang","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"R10-17-20210204","first-page":"18","article-title":"Kuroki M, et al. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.","volume":"39","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-17-20210204","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1128\/JVI.75.20.9828-9835.2001","article-title":"Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.","volume":"75","author":"Zheng","year":"2001","journal-title":"J Virol"},{"key":"R12-17-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R13-17-20210204","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004170100285","article-title":"Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years results of a randomized prospective clinical trial.","volume":"239","author":"Reinhard","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-17-20210204","first-page":"381","article-title":"Topical immunosuppressives after penetrating keratoplasty.","volume":"104","author":"Bienbaum","year":"2007","journal-title":"Ophthalmologe"},{"key":"R15-17-20210204","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.TP.0000158022.62059.F2","article-title":"Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.","volume":"79","author":"Bienbaum","year":"2005","journal-title":"Transplantation"},{"key":"R16-17-20210204","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s004170050330","article-title":"Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency.","volume":"237","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R17-17-20210204","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0039-6257(78)90197-2","article-title":"Glucocorticoid therapy in ocular herpes simplex I. Limitations.","volume":"23","author":"Ostler","year":"1978","journal-title":"Surv Ophthalmol"},{"key":"R18-17-20210204","doi-asserted-by":"crossref","first-page":"c2459","DOI":"10.1136\/bmj.c2459","article-title":"Bevacizumab for neovascular age related macular degeneration (ABC trial): multicentre randomised double masked study.","volume":"340","author":"Tufail","year":"2010","journal-title":"BMJ"},{"key":"R19-17-20210204","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archophthalmol.2008.1","article-title":"Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.","volume":"126","author":"Kong","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R20-17-20210204","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archopht.126.7.941","article-title":"Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration.","volume":"126","author":"Chang","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R21-17-20210204","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization.","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"R22-17-20210204","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab in corneal neovascularization.","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"R23-17-20210204","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R24-17-20210204","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.ico.0000611440.32234.8f","article-title":"Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis.","volume":"27","author":"Carrasco","year":"2008","journal-title":"Cornea"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003226-201202000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:47:23Z","timestamp":1618278443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201202000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31820ca19e","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}